Rani Therapeutics dismisses EY as auditor, appoints Marcum; EY's 2023 report had going concern doubt

Rani Therapeutics Holdings, Inc.

EY dismissed as independent auditor on Sep 10, 2024; Marcum LLP appointed immediately.
EY's 2023 audit opinion included a going concern explanatory paragraph about substantial doubt.
No disagreements or reportable events in fiscal 2022, 2023, or subsequent interim period.
Letter from EY to SEC confirming agreement attached as Exhibit 16.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.